Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsule
Product Images NDC 0276-0500

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 0276-0500). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Misemer Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chlordiazepoxide (Chlordiazepoxide)

Chemical structure of Chlordiazepoxide Hydrochloride shown as a molecular diagram with labeled atoms and bonds, including a benzene ring substituted with chlorine and other functional groups.*

FDA Label Image

Clidinium (Clidinium)

Chemical structure of Clidinium Bromide, an active ingredient in Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules by Misemer Pharmaceuticals, Inc.*

FDA Label Image

Label (Label)

Label for Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules containing 5 mg and 2.5 mg respectively. The label includes dosage instructions, storage conditions, and pharmacist guidance. It also displays the product NDC 0276-0500-10, manufacturer Misemer Pharmaceuticals, Inc, and states it is a human prescription drug. The label specifies the package contains 100 capsules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.